Giovanni Minisola

Giovanni Minisola

Auto-generated profile, based on publicly available information

Giovanni Minisola

Ospedale San Camillo, 00152 Rome, Italy

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2010 in Arthritis Research & Therapy
Verified
Journal Article
Open access
MRMaurizio Rossini
Maurizio Rossini
SBSusanna Maddali Bongi
Susanna Maddali Bongi
GMGiovanni La Montagna
Giovanni La Montagna
GMGiovanni Minisola
Giovanni Minisola
NMNazzarena Malavolta
Nazzarena Malavolta
SASilvano Adami
Silvano Adami
Introduction: The aim of this study was to estimate the prevalence and determinants of vitamin D deficiency in patients with rheumatoid arthritis (RA) as compared to healthy controls and to analyze the association between 25-hydroxyvitamin D (25(OH)D) with disease activity and disability. Methods: The study includes 1,191 consecutive RA patients (85% women) and 1,019 controls, not on vitamin D supplements, from 22 Italian rheumatology centres. Together with parameters of disease activity, functional impairment, and mean sun exposure time, all patients had serum 25(OH)D measured in a centralized laboratory. Results: A total of 55% of RA patients were not taking vitamin D supplements; the proportion of these with vitamin D deficiency (25(OH)D level <20 ng/ml) was 52%. This proportion was similar to that observed in control subjects (58.7%). One third of supplemented patients were still vitamin D deficient. In non-supplemented RA patients 25(OH)D levels were negatively correlated with the Health Assessment Questionnaire Disability Index, Disease Activity Score (DAS28), and Mobility Activities of daily living score. Significantly lower 25(OH)D values were found in patients not in disease remission or responding poorly to treatment, and with the highest Steinbrocker functional state. Body mass index (BMI) and sun exposure time were good predictors of 25(OH)D values (P < 0.001). The association between disease activity or functional scores and 25(OH)D levels remained statistically significant even after adjusting 25(OH)D levels for both BMI and sun exposure time. Conclusions: In RA patients vitamin D deficiency is quite common, but similar to that found in control subjects; disease activity and disability scores are inversely related to 25(OH)D levels.

3 September 2013 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
CSCarlo Alberto Scirè
Carlo Alberto Scirè
MMMaria Manara
Maria Manara
MCMarco Amedeo Cimmino
Marco Amedeo Cimmino
MGMarcello Govoni
Marcello Govoni
FSFausto Salaffi
Fausto Salaffi
KCKING Study Collaborators
KING Study Collaborators
Introduction: Gout is the most prevalent arthritis and significantly impacts on function and quality of life. Given that gout associates with disabling comorbid conditions, it is not clear whether such a complex of diseases accounts for the increased disability or if gout may play a role by itself. This study aims to evaluate the specific influence of gout and disease-related features on functional disability and health-related quality of life (HRQoL) in patients with gout followed in rheumatology clinics. Methods: A random sample of patients was drawn from clinical registries of 30 rheumatology clinics across Italy. Sociodemographic, general health and gout-specific variables were collected. Functional disability and HRQoL were assessed by the health assessment questionnaire (HAQ) and the Physical and Mental Component Summary scores (PCS and MCS) of the Short Form-36 (SF-36). Crude and adjusted ordinal logistic and linear regression models were applied to investigate the specific contribution of different variables on HAQ and SF-36 scores. Results are presented as odds ratio (OR) or mean difference (MD) and 95% confidence intervals. Results: Out of 446 patients with gout, 90% were males with a mean age of 63.9 years and median disease duration of 3.8 years; the majority of patients were overweight or obese, and with several comorbidities; 21.1% showed at least moderate disability; the PCS score was significantly lower than expected age- and gender-matched samples in the general population, while MCS score was not. After adjusting for potential sociodemographic and general-health confounders, gout-specific variables significantly impacted on HAQ, including polyarticular involvement OR 3.82 (1.63, 8.95), presence of tophi OR 1.92 (1.07, 3.43) and recent attacks OR 2.20 (1.27, 3.81). Consistent results were found for PCS. The impairment of PCS compared to the general population was limited to patients with features of chronic gout. MCS was only affected by recent attacks (MD -2.72 [-4.58, -0.86]) and corticosteroid treatment (-3.39 [-5.30,-1.48]). Conclusions: The data from the KING study confirm that gout impacts on disability and provide evidence for an independent association of gout and gout-related features with functional outcome and HRQoL. This result supports the need to improve specific treatment in gout.

1 April 2016 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
AGATLANTIS study group
ATLANTIS study group
RRRoberta Ramonda
Roberta Ramonda
AMAntonio Marchesoni
Antonio Marchesoni
ACAntonio Carletto
Antonio Carletto
GBGerolamo Bianchi
Gerolamo Bianchi
IOIgnazio Olivieri
Ignazio Olivieri
The aim was to establish how patients experience the impact of spondyloarthritis (SpA) on work disability and working life. The survey was performed in 17/20 regions in Italy (1 January to 31 March 2013). A multiple-choice questionnaire was published on the official website of the sponsor - the National Association of Rheumatic Patients (ANMAR) - and hard-copies were distributed at outpatient clinics for rheumatic patients. Respondents (n = 770) were of both sexes (56 % men), educated (62 % at high school or more), of working age (75 % aged ≤60 years), and affected by SpA. The most common types diagnosed were ankylosing spondylitis (AS) (39 %) and psoriatic arthritis (PsA) (36 %). Respondents were working full-time (45 %), part-time (8 %) or had retired (22 %); 15 % were unemployed (for reasons linked to the disease or for other reasons, students or housewives). Patients reported disability (39 %), were receiving disability benefits (34 %), were experiencing important limitations that were hindering their professional development/career (36 %) and some had to change/leave their job or lost it because of SpA (21 %). Employed respondents (n = 383) had worked on average 32.2 h in the last 7 days. More hours of work were lost over the last 7 days due to SpA (2.39 h vs 1.67 h). The indirect costs of the disease amounted to €106/week for patients reporting well-being/good physical conditions/improvement and €216/week for those reporting permanent impairment. Most patients were in the midst of their productive years and were experiencing considerable difficulties in carrying out their job because of the disease: half of them reported disability and one third were experiencing important limitations in their career perspective.

1 July 2004
Verified
Journal Article
Closed access
OMOmbretta Di Munno
Ombretta Di Munno
MMMaurizio Mazzantini
Maurizio Mazzantini
LSLuigi Sinigaglia
Luigi Sinigaglia
GBGerolamo Bianchi
Gerolamo Bianchi
GMGiovanni Minisola
Giovanni Minisola
SASilvano Adami
Silvano Adami

17 October 2012
Verified
Journal Article
Closed access
MVMassimo Varenna
Massimo Varenna
MMMaria Manara
Maria Manara
FCFrancesco P Cantatore
Francesco P Cantatore
APAntonio Del Puente
Antonio Del Puente
OMOmbretta Di Munno
Ombretta Di Munno
MRMaurizio Rossini
Maurizio Rossini

28 May 2016
Verified
Journal Article
Closed access
GSGian D Sebastiani
Gian D Sebastiani
IPImmacolata Prevete
Immacolata Prevete
AIAnna Iuliano
Anna Iuliano
GMGiovanni Minisola
Giovanni Minisola